Quick Answer
Pulmonx Corp reported Long Term Debt of $36.99 million for the year ending 2025.
- Pulmonx Corp showed an increase of +8.8% in Long Term Debt from 2024 to 2025.
- This data is from Pulmonx Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2021: $17.32 million | Q1 2022: $16.63 million | Q2 2022: $14.46 million | Q3 2022: $12.34 million | Q1 2023: $37.17 million | Q2 2023: $37.15 million | Q3 2023: $37.15 million | Q1 2024: $32.00 million | Q2 2024: $37.11 million | Q3 2024: $37.14 million | Q1 2025: $29.39 million | Q2 2025: $37.01 million | Q3 2025: $37.03 million.
- Over the full 4 years of available data (2022 to 2025), Pulmonx Corp's Long Term Debt has grown by 114.6%.
- Historical annual values: Fiscal year 2025: $36.99 million | Fiscal year 2024: $34.00 million | Fiscal year 2023: $35.09 million | Fiscal year 2022: $17.23 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: